Evidence map›Paper›PMID 35212715›Full record

ArticleCardiovascular research2022

Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression.

Ian R McCracken, Ross Dobie, Matthew Bennett, Rainha Passi, Abdelaziz Beqqali, Neil C Henderson, Joanne C Mountford, Paul R Riley, Chris P Ponting, Nicola Smart and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Feto-placental blood vessel development.Development (Cambridge, England) · 2025
    Review
  16. Review
  17. Dissecting endothelial cell heterogeneity with new tools.Cell regeneration (London, England) · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Ian R McCrackenCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-8806-548X
Ross DobieCentre for Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-9516-315X
Matthew BennettCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0001-9819-3397
Rainha PassiCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Abdelaziz BeqqaliCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Neil C HendersonCentre for Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0002-2273-4094
Joanne C MountfordScottish National Blood Transfusion Service, Edinburgh EH14 4BE, UK.ORCID 0000-0003-2142-6572
Paul R RileyDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford OX1 3PT, UK.ORCID 0000-0002-9862-7332
Chris P PontingMRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh EH4 2XU, UK.ORCID 0000-0003-0202-7816
Nicola SmartDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford OX1 3PT, UK.ORCID 0000-0002-3501-7254
Mairi BrittanCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0002-3830-200X
Andrew H BakerCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0003-1441-5576
University of Edinburgh · GBUniversity of Oxford · GBCentre for Inflammation Research · GBInstitute of Genetics and Cancer · GBMaastricht University · NLScottish National Blood Transfusion Service · GB

Funding

British Heart Foundation CH/11/2/28733British Heart Foundation FS/16/4/31831British Heart Foundation FS/19/32/34376Chief Scientist Office CGA/19/18Medical Research Council MC_PC_15075Medical Research Council MC_UU_00007/15Medical Research Council MC_UU_12008/1Medical Research Council MR/R006237/1Wellcome Trust
6 · The paper itself

Abstract

aimsCoronary vasculature formation is a critical event during cardiac development, essential for heart function throughout perinatal and adult life. However, current understanding of coronary vascular development has largely been derived from transgenic mouse models. The aim of this study was to characterize the transcriptome of the human foetal cardiac endothelium using single-cell RNA sequencing (scRNA-seq) to provide critical new insights into the cellular heterogeneity and transcriptional dynamics that underpin endothelial specification within the vasculature of the developing heart. METHODS AND

resultsWe acquired scRNA-seq data of over 10 000 foetal cardiac endothelial cells (ECs), revealing divergent EC subtypes including endocardial, capillary, venous, arterial, and lymphatic populations. Gene regulatory network analyses predicted roles for SMAD1 and MECOM in determining the identity of capillary and arterial populations, respectively. Trajectory inference analysis suggested an endocardial contribution to the coronary vasculature and subsequent arterialization of capillary endothelium accompanied by increasing MECOM expression. Comparative analysis of equivalent data from murine cardiac development demonstrated that transcriptional signatures defining endothelial subpopulations are largely conserved between human and mouse. Comprehensive characterization of the transcriptional response to MECOM knockdown in human embryonic stem cell-derived EC (hESC-EC) demonstrated an increase in the expression of non-arterial markers, including those enriched in venous EC.

conclusionsscRNA-seq of the human foetal cardiac endothelium identified distinct EC populations. A predicted endocardial contribution to the developing coronary vasculature was identified, as well as subsequent arterial specification of capillary EC. Loss of MECOM in hESC-EC increased expression of non-arterial markers, suggesting a role in maintaining arterial EC identity.

Indexed as

Endothelial CellsHeartAnimalsEndothelium, VascularHumansMDS1 and EVI1 Complex Locus ProteinMiceMice, TransgenicTranscription FactorsTranscriptomeMDS1 and EVI1 Complex Locus ProteinMECOM protein, humanTranscription FactorsCoronary vasculature formationEndothelial heterogeneityHuman cardiac developmentMECOMSingle-cell RNA sequencingVascular regeneration

Identifiers

PMID35212715
PMCPMC9648824
OpenAlexW4213435641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.